remibrutinib
Showing 1 - 7 of 7
Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)
Not yet recruiting
- Chronic Spontaneous Urticaria
- Remibrutinib
- +3 more
- (no location specified)
Sep 20, 2023
Chronic Inducible Urticaria Trial (Remibrutinib, Placebo)
Not yet recruiting
- Chronic Inducible Urticaria
- Remibrutinib
- Placebo
- (no location specified)
Jul 28, 2023
Allergy, Peanut Trial (remibrutinib, )
Not yet recruiting
- Allergy, Peanut
- remibrutinib
- placebo
- (no location specified)
Jun 20, 2022
Chronic Spontaneous Urticaria Trial (Remibrutinib)
Available
- Chronic Spontaneous Urticaria
- Remibrutinib
- (no location specified)
Dec 9, 2021
Relapsing Multiple Sclerosis Trial in Worldwide (Remibrutinib, Teriflunomide)
Recruiting
- Relapsing Multiple Sclerosis
- Remibrutinib
- Teriflunomide
-
Fullerton, California
- +38 more
Aug 12, 2022
Relapsing Multiple Sclerosis Trial in Worldwide (Remibrutinib, Teriflunomide)
Recruiting
- Relapsing Multiple Sclerosis
- Remibrutinib
- Teriflunomide
-
Hanford, California
- +41 more
Aug 5, 2022
Sjögren Syndrome Trial in Worldwide (LOU064, Placebo)
Terminated
- Sjögren Syndrome
- Remibrutinib
- Placebo
-
Boston, Massachusetts
- +25 more
Jan 27, 2023